Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy

[This corrects the article DOI: 10.1186/s13223-020-00419-z.].

Saved in:
Bibliographic Details
Published in:Allergy, asthma, and clinical immunology asthma, and clinical immunology, 2020-05, Vol.16 (1), p.38-38, Article 38
Main Authors: Langlois, Alexandra, Lavergne, Marie-Hélène, Leroux, Hélène, Killer, Kerstin, Azzano, Pauline, Paradis, Louis, Samaan, Kathryn, Lacombe-Barrios, Jonathan, Eiwegger, Thomas, Upton, Julia, Sussman, Gordon, Poder, Thomas, Mâsse, Benoît, Roches, Anne Des, Bégin, Philippe
Format: Article
Language:English
Subjects:
Immunotherapy
Omalizumab
Pharmaceutical industry
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[This corrects the article DOI: 10.1186/s13223-020-00419-z.].
ISSN:1710-1484
1710-1492
1710-1492
DOI:10.1186/s13223-020-00435-z